UPDATE 2-Zogenix’s seizure drug clears late-stage trial, shares soar

This post was originally published on this site

Zogenix Inc said on Thursday
its drug to treat a rare form of childhood epilepsy reduced
convulsive seizures in a second late-stage trial, sending the
drug developer’s shares up as much as 26 percent.